In a filing, enVVeno Medical Corporation revealed its Director Duhay Francis acquired Company’s shares for reported $0.25 million on Dec 31 ’24. In the deal valued at $3.07 per share,81,433 shares were bought. As a result of this transaction, Duhay Francis now holds 102,344 shares worth roughly $0.4 million.
Then, Gray Robert bought 3,500 shares, generating $10,290 in total proceeds. Upon buying the shares at $2.94, the Director now owns 11,155 shares.
Before that, Shrivastava Sanjay bought 5,400 shares. enVVeno Medical Corporation shares valued at $15,660 were divested by the Director at a price of $2.90 per share. As a result of the transaction, Shrivastava Sanjay now holds 9,288 shares, worth roughly $36316.08.
Price Performance Review of NVNO
On Friday, enVVeno Medical Corporation [NASDAQ:NVNO] saw its stock jump 2.22% to $3.91. Over the last five days, the stock has gained 11.54%. enVVeno Medical Corporation shares have risen nearly 29.64% since the year began. Nevertheless, the stocks have fallen -17.58% over the past one year. While a 52-week high of $6.48 was reached on 06/06/25, a 52-week low of $2.03 was recorded on 04/09/25. SMA at 50 days reached $3.10, while 200 days put it at $3.43.
Levels Of Support And Resistance For NVNO Stock
The 24-hour chart illustrates a support level at 3.39, which if violated will result in even more drops to 2.96. On the upside, there is a resistance level at 4.43. A further resistance level may holdings at 5.04. The Relative Strength Index (RSI) on the 14-day chart is 60.22, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.14, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 50.58%. Stochastics %K at 43.52% indicates the stock is a holding.
